(Q44397235)

2 December 2017

title

Results of first salvage therapy for patients refractory to a fludarabine regimen in chronic lymphocytic leukemia (English)

1 reference

2 December 2017

0 references

1 reference

Keating MJ

1

1 reference

2 December 2017

O'Brien S

2

1 reference

2 December 2017

Kontoyiannis D

3

1 reference

2 December 2017

Plunkett W

4

1 reference

2 December 2017

Koller C

5

1 reference

2 December 2017

Beran M

6

1 reference

2 December 2017

Lerner S

7

1 reference

2 December 2017

Kantarjian H

8

1 reference

2 December 2017

publication date

1 September 2002

1 reference

2 December 2017

1 reference

2 December 2017

volume

43

1 reference

2 December 2017

issue

9

1 reference

2 December 2017

page(s)

1755-1762

1 reference

The treatment of chronic lymphocytic leukemia with COP chemotherapy

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000006547

2-Chlorodeoxyadenosine Treatment of Refractory Chronic Lymphocytic Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000006547

Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000006547

HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000006547

Rituximab dose-escalation trial in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000006547

Fludarabine and granulocyte colony-stimulating factor (G-CSF) in patients with chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000006547

Response to 2-chlorodeoxyadenosine in patients with B-cell chronic lymphocytic leukemia resistant to fludarabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000006547

Lack of effect of 2-chlorodeoxyadenosine therapy in patients with chronic lymphocytic leukemia refractory to fludarabine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000006547

In vitro growth in acute myeloblastic leukemia: clinico-biological correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000006547

Humanized CD52 monoclonal antibody campath-1H as first-line treatment in chronic lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000006547

10.1080/1042819021000006547

21 January 2018

Identifiers

DOI

1 reference

2 December 2017

1 reference